• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION TAXUS LIBERTE; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION TAXUS LIBERTE; CORONARY DRUG-ELUTING STENT Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Angina (1710); Restenosis (4576)
Event Date 11/02/2021
Event Type  Injury  
Event Description
(b)(4).It was reported that stable angina and in stent restenosis (isr) occurred.On an unknown date the lad was treated with angioplasty using a 3mm x 20mm taxus drug eluting stent and a 2.75mm x 32mm taxus drug eluting stent.On (b)(6) 2021, the subject presented for the index procedure with stable angina.Angiography revealed 90% in stent restenosis of the lad.Heparin or other antithrombotic medication were administered at the time of the index procedure.The subject was on a prior regime of aspirin (>= 72 hours) and antiplatelet other than aspirin >=72 hours) medications at the time of the index procedure.The target lesion was located in the proximal lad and was 10mm long with a reference vessel diameter of 2.75mm.The lesion was predilated with a 2.5mm x 15mm balloon with 30% residual stenosis and timi flow 3.Following pre dilation, the lesion was treated with a 2.50mm x 30mm study device successfully with 0% residual stenosis and timi flow 3.Post dilation was not performed.On 03 nov 2021, the subject was discharged on aspirin and clopidogrel.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TAXUS LIBERTE
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key13863601
MDR Text Key288091764
Report Number2134265-2022-03290
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 03/22/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/23/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/04/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age69 YR
Patient SexMale
Patient RaceWhite
-
-